Higher dopamine transporter density in Parkinson's disease patients with depression

Psychopharmacology

Volumn 211, Issue 1, 2010, Pages 27-31

  Felicio, Andre C ^a,b   Moriyama, Tais S ^a,b   Godeiro Jr , Clecio ^a,b   Shih, Ming C ^a,b   Hoexter, Marcelo Q ^a,b   Borges, Vanderci ^b   Silva, Sonia M A ^b   Amaro Jr , Edson ^a   Andrade, Luiz A F ^a   Ferraz, Henrique B ^b   Bressan, Rodrigo A ^a,b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Depression; Dopamine transporter; Parkinson's disease (PD); SPECT

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; DOPAMINE TRANSPORTER;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; NEUROIMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; BRAIN; CASE-CONTROL STUDIES; DEPRESSION; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PARKINSON DISEASE; PROTEIN BINDING; RADIOPHARMACEUTICALS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 77955573698     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1867-y     Document Type: Article

References (18)

1. Argyelan M, Szabo Z, Kanyo B, Tanacs A, Kovacs Z, Janka Z, Pavics L (2005) Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord 89:115-123
2. Bressan RA, Shih MC, Hoexter MQ, Lacerda AL (2007) Can molecular imaging techniques identify biomarkers for neuropsy-chiatric disorders? Rev Bras Psiquiatr 29:102-104
3. Broussolle E, Dentresangle C, Landais P, Garcia-Larrea L, Pollak P, Croisile B, Hibert O, Bonnefoi F, Galy G, Froment JC, Comar D (1999) The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci 166:141-151
4. 99mTc]TRODAT-1 SPECT imaging. Am J Psychiatry 160:1836-1841
5. Felicio AC, Godeiro-Junior C, Shih MC, Borges V, Silva SM, Aguiar PD, Hoexter MQ, Barsottini OG, Andrade LA, Bressan RA, Ferraz HB (2010) Evaluation of patients with clinically unclear Parkinsonian syndromes submitted to brain SPECT imaging using the technetium-99 m labeled tracer TRODAT-1. J Neurol Sci 291:64-68
6. Hesse S, Meyer PM, Strecker K, Barthel H, Wegner F, Oehlwein C, Isaias IU, Schwarz J, Sabri O (2009) Monoamine transporter availability in Parkinson's disease patients with or without depression. Eur J Nucl Med Mol Imaging 36:428-435
7. Koerts J, Leenders KL, Koning M, Portman AT, van Beilen M (2007) Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease. Eur J Neurosci 25:3132-3136
8. Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J (1999) Striatal dopamine transporter density in major depression. Psychopharmacology 144:282-285
9. Lehto SM, Tolmunen T, Kuikka J, Valkonen-Korhonen M, Joensuu M, Saarinen PI, Vanninen R, Ahola P, Tiihonen J, Lehtonen J (2008) Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study Neurosci Lett 441:291-295
10. Meyer JH, Krüger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, Minifie C, Houle S, Hussey D, Kennedy SH (2001) Lower dopamine transporter binding potential in striatum during depression. NeuroReport 12:4121-4125
11. Murai T, Müller U, Werheid K, Sorger D, Reuter M, Becker T, von Cramon DY, Barthel H (2001) In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease. J Neuropsychiatry Clin Neurosci 13:222-228
12. Rektorova I, Srovnalova H, Kubikova R, Prasek J (2008) Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease. Mov Disord 23:1580-1587
13. Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314-1322
14. Rickards H (2005) Depression in neurological disordes: Parkinson's disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry 76:48-52
15. Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S (2006) Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res 147:243-248
16. Tumas V, Rodrigues GG, Farias TL, Crippa JA (2008) The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory. Arq Neuro-psiquiatr 66:152-156
17. Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR (2005) Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 46:227-232 (Pubitemid 43073428)
18. Yang YK, Yeh TL, Yao WJ, Lee IH, Chen PS, Chiu NT, Lu RB (2008) Greater availability of dopamine transporters in patients with major depression-a dual-isotope SPECT study. Psychiatry Res 162:230-235